Αρχική World News Lack of Immunity Against SARS-CoV-2 in a Large Tertiary Care Centre in...

Lack of Immunity Against SARS-CoV-2 in a Large Tertiary Care Centre in Vienna

The results from a study that aimed to perform serological testing and evaluate SARS-CoV-2 antibody levels in oncological healthcare workers and cancer patients irrespective of COVID-19 symptoms after implementation of institutional safety measures in a large tertiary care hospital in Vienna, Austria indicate low prevalence of anti-SARS-CoV-2 antibodies in both cohorts, thus indicating a lack of immunity against SARS-CoV-2. The findings highlight the need for continuation of strict safety measures to prevent uncontrolled viral spread according Prof. Thorsten Füreder of the Department of Medicine I, Division of Oncology, Medical University of Vienna in Vienna, Austria and colleagues who published their results on 2 September 2020 in the ESMO Open.

The authors wrote that the SARS-CoV-2 seroprevalence in oncological healthcare workers and the cancer patients has significant implications in terms of cancer care delivery and policy-making decisions.

Between 21 March and 4 June 2020, the oncology healthcare workers and cancer patients were tested for total antibodies against SARS-CoV-2 at the Medical University of Vienna. The study team used the Roche Elecsys® Anti-SARS-CoV-2 immunoassay and reactive samples were additionally tested by the Abbott® SARS-CoV-2 IgG test. Oncology healthcare workers had also to complete a questionnaire regarding demographic parameters, travel history and presence of COVID-19 symptoms.

The study team enrolled 62 oncology healthcare workers and 84 cancer patients. In the cohort of oncological healthcare workers, 20 (32.3%) of tested individuals were medical oncologists, 28 (45.2%) oncology nurses and 14 (22.6%) other, e.g. study coordinators. In the patient cohort, most of those tested were on active anticancer treatment (96.4%).

Since the end of February 2020, 26% of the oncology healthcare workers and 6% of cancer patients had symptoms that could be potentially associated with COVID-19. However, anti-SARS-Cov-2 total antibodies were detected in only 2 (3.2%) oncology healthcare workers and in 3 (3.6%) cancer patients. The second assay for anti-SARS-Cov-2 IgG antibodies confirmed the positive result in all oncology healthcare workers and in 2 (2.4%) cancer patients, suggesting an initial assay’s unspecific reaction in only one case.

Specific anti-SARS-CoV-2 antibodies were found solely in individuals after a documented SARS-CoV-2 viral infection, thus supporting the test methods’ high sensitivity and specificity. In persons with a confirmed test result, an active COVID-19 infection was documented by a positive SARS-CoV-2 RNA PCR test.

The authors wrote that although 26% of the oncological healthcare workers reported symptoms potentially associated with COVID-19, only a minority had specific anti-SARS-Cov-2 antibodies. Contrary to oncological healthcare workers, anti-SARS-CoV-2 total antibodies were detected in three asymptomatic cancer patients, but were not confirmed in one patient by a second assay for anti-SARS-CoV-2 IgG antibodies. In general, the prevalence of anti-SARS-CoV-2 antibodies in oncological healthcare workers and cancer patients is low and indicates a lack of immunity against SARS-CoV-2, thus requiring continuation of strict safety measures.


Fuereder T, Berghoff AS, Heller G, et al. SARS-CoV-2 seroprevalence in oncology health care professionals and cancer patients at a tertiary care center during the COVID-19 pandemic. ESMO Open; Published online 2 September 2020. DOI: 10.1136/esmoopen-2020-000889 



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer that’s not spread elsewhere in the body. “Today’s results are the...

New Combination of Old Drugs Improves Survival in Patients with Prostate Cancer [ESMO Congress 2021 Press Release]

LBA4_PR - Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men...

Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO Congress 2021 Press Release]

LBA2_PR - Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase 3 KEYNOTE-826 study N. Colombo1, C....

Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App

Jessica Baladad has had a long history with self-examinations after a breast cancer scare in her early 20s. This habit helped save her life,...

Extended Adjuvant Treatment with Letrozole Results in Longer Survival in Postmenopausal Patients with Breast Cancer

According to results from a prospective, open-label, phase III study conducted in 69 Italian hospitals within the Gruppo Italiano Mammella among the postmenopausal patients...

Foodie Fridays: Apple Bok Choy Salad

While the temps may still be in the 80’s, apple season is upon us! Give this Apple Bok Choy salad a try!  It is...